Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 15, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Amended on May 16, 2022 – the version known today is shown.

You are looking at Q3 2021. Go to the latest filing (Q3 2026)

36.4B USDQ3 2021
Total value of stock positions
36.4B USD
Positions
95
Share of the ten largest
38.8%

The ten largest positions Q3 2021

  1. Ginkgo Bioworks Holdings Inc 10.8%new
  2. GE Aerospace 4.8%▲ +47.5%
  3. T-Mobile US 3.6%▲ +35.6%
  4. Bridgebio Pharma Inc 3.4%unchanged
  5. Humana 3.2%▲ +411.2%
  6. Microsoft 2.8%▼ −21.8%
  7. Adaptive Biotechnologies Cor 2.8%unchanged
  8. Brookfield Asset Mgmt Inc 2.5%▲ +311.2%
  9. Fidelity National Information Services 2.4%▼ −22.0%
  10. Parker Hannifin 2.4%▲ +365.6%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q3 2021

Positions Q3 2021 per 13F filing, 50 of 95
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 1.8% 202,908 666.6M USD −57.2% reduced Q2 2015 26 quarters
MSFT Microsoft 2.8% 3,641,547 1.0B USD −21.8% reduced Q2 2016 22 quarters
V Visa Inc. 1.6% 2,636,735 587.3M USD +18.8% increased Q3 2016 21 quarters
Catalent Inc 0.4% 1,163,034 154.8M USD +4.0% increased Q1 2018 15 quarters
CNC Centene Corporation 1.7% 9,884,106 615.9M USD −11.7% reduced Q2 2018 14 quarters
BSX Boston Scientific 0.8% 6,866,405 297.9M USD −48.4% reduced Q3 2018 13 quarters
Bridgebio Pharma Inc 3.4% 26,620,991 1.2B USD unchanged Q2 2019 10 quarters
Adaptive Biotechnologies Cor 2.8% 29,993,708 1.0B USD unchanged Q2 2019 10 quarters
Avantor Inc 0.8% 7,121,192 291.3M USD −39.3% reduced Q2 2019 10 quarters
AIZ Assurant 0.8% 1,817,833 286.8M USD −24.6% reduced Q2 2019 10 quarters
FTV Fortive 2.1% 10,808,273 762.7M USD −8.2% reduced Q3 2019 9 quarters
Guardant Health Inc 1.7% 4,894,936 611.9M USD +15.0% increased Q3 2019 9 quarters
Molina Healthcare Inc 0.7% 935,226 253.7M USD −3.9% reduced Q3 2019 9 quarters
FIS Fidelity National Information Services 2.4% 7,172,066 872.7M USD −22.0% reduced Q4 2019 8 quarters
TMUS T-Mobile US 3.6% 10,225,185 1.3B USD +35.6% increased Q1 2020 7 quarters
CB Chubb Limited 1.5% 3,039,945 527.4M USD −38.2% reduced Q1 2020 7 quarters
IR Ingersoll Rand 0.5% 3,641,009 183.5M USD −43.3% reduced Q1 2020 7 quarters
PH Parker Hannifin 2.4% 3,101,255 867.2M USD +365.6% increased Q2 2020 6 quarters
Api Group Corp 1.9% 33,333,333 678.3M USD unchanged Q2 2020 6 quarters
Royalty Pharma PLC 0.4% 4,140,508 149.6M USD +27.8% increased Q2 2020 6 quarters
Zentalis Pharmaceuticals Inc 0.4% 2,118,284 141.2M USD −11.7% reduced Q2 2020 6 quarters
Pvh Corporation 0.3% 1,161,695 119.4M USD +81.7% increased Q2 2020 6 quarters
TMO Thermo Fisher Scientific 0.3% 182,237 104.1M USD −82.0% reduced Q2 2020 6 quarters
ALGN Align Technology 0.2% 111,570 74.2M USD −72.4% reduced Q2 2020 6 quarters
Fleetcor Technologies Inc 1.8% 2,468,612 645.0M USD −14.1% reduced Q3 2020 5 quarters
ZBH Zimmer Biomet 1.4% 3,409,073 499.0M USD +15.4% increased Q3 2020 5 quarters
SNOW Snowflake 1.2% 1,436,335 434.4M USD +163.2% increased Q3 2020 5 quarters
BMY Bristol Myers Squibb 1.1% 7,023,264 415.6M USD −37.9% reduced Q3 2020 5 quarters
PODD Insulet Corporation 0.8% 1,013,141 288.0M USD −36.5% reduced Q3 2020 5 quarters
Laboratory Corp Amer HLDGS 0.6% 791,746 222.8M USD −42.4% reduced Q3 2020 5 quarters
Inhibrx Inc 0.5% 5,305,866 176.7M USD unchanged Q3 2020 5 quarters
Karuna Therapeutics Inc 0.3% 868,696 106.3M USD +5.6% increased Q3 2020 5 quarters
Pmv Pharmaceuticals Inc 0.1% 1,790,284 53.4M USD unchanged Q3 2020 5 quarters
GE GE Aerospace 4.8% 16,923,702 1.7B USD +47.5% increasedafter 1:8 stock split Q4 2020 4 quarters
PANW Palo Alto Networks 1.7% 1,273,598 610.1M USD −51.8% reduced Q4 2020 4 quarters
META Meta Platforms 1.6% 1,705,703 578.9M USD −16.0% reduced Q4 2020 4 quarters
NOW ServiceNow 1.0% 559,395 348.1M USD −62.3% reduced Q4 2020 4 quarters
UNH UnitedHealth Group 0.8% 726,474 283.9M USD −59.6% reduced Q4 2020 4 quarters
Match Group Inc New 0.6% 1,365,007 214.3M USD −42.1% reduced Q4 2020 4 quarters
MRSH Marsh McLennan 0.5% 1,156,185 175.1M USD −43.8% reduced Q4 2020 4 quarters
Acadia Healthcare Company In 0.4% 2,102,758 134.1M USD +2.1% increased Q4 2020 4 quarters
4D Molecular Therapeutics In 0.3% 3,937,914 106.2M USD unchanged Q4 2020 4 quarters
Kinnate Biopharma Inc 0.1% 1,820,462 41.9M USD unchanged Q4 2020 4 quarters
BILI Bilibili < 0.1% 547,961 36.3M USD +105.6% increased Q4 2020 4 quarters
Coupa Software Inc 2.4% 3,917,895 858.7M USD +8.8% increased Q1 2021 3 quarters
RUN Sunrun 1.1% 8,800,183 387.2M USD +97.1% increased Q1 2021 3 quarters
AMP Ameriprise Financial 1.0% 1,400,867 370.0M USD −9.0% reduced Q1 2021 3 quarters
Zai Lab Ltd 0.9% 2,932,456 309.1M USD – Q1 2021 3 quarters
Lithia Mtrs Inc 0.7% 803,472 254.7M USD −0.5% reduced Q1 2021 3 quarters
NFLX Netflix 0.7% 410,913 250.8M USD −53.2% reduced Q1 2021 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 95 positions.

Plus 1 position in convertible bonds and bonds worth 108.4M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Coupa Software Inc principal 100.0M USD 108.4M USD

Breakdown by sector

  • Industrials 12.3%
  • Health Care 10.7%
  • Financials 8.7%
  • Communication Services 7.4%
  • Technology 6.7%
  • Consumer Discretionary 3.5%
  • not in our coverage 50.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close